Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - NetInterest Income - TotalInterest income - LoansNet Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesOther interest incomePreferred Dividend PaymentsProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Broadway Financial (BYFC) Research & Development (2016 - 2025)

Historic Research & Development for Broadway Financial (BYFC) over the last 11 years, with Q3 2025 value amounting to $768000.0.

  • Broadway Financial's Research & Development rose 185.68% to $768000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 486.74%. This contributed to the annual value of $2.8 million for FY2024, which is 50.41% down from last year.
  • Broadway Financial's Research & Development amounted to $768000.0 in Q3 2025, which was up 185.68% from $774000.0 recorded in Q2 2025.
  • In the past 5 years, Broadway Financial's Research & Development registered a high of $2.2 million during Q4 2021, and its lowest value of $241000.0 during Q1 2021.
  • For the 5-year period, Broadway Financial's Research & Development averaged around $765157.9, with its median value being $715000.0 (2023).
  • Its Research & Development has fluctuated over the past 5 years, first surged by 83797.47% in 2021, then plummeted by 7440.4% in 2022.
  • Quarter analysis of 5 years shows Broadway Financial's Research & Development stood at $2.2 million in 2021, then tumbled by 74.4% to $569000.0 in 2022, then increased by 10.54% to $629000.0 in 2023, then increased by 1.59% to $639000.0 in 2024, then grew by 20.19% to $768000.0 in 2025.
  • Its Research & Development was $768000.0 in Q3 2025, compared to $774000.0 in Q2 2025 and $706000.0 in Q1 2025.